SERT
9 drugs CNS
4
approved indications
9
Approved Drugs
8
Companies
5
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (8 companies)
✓ All 9 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (5 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
AbbVie 2 drugs
MEDICAP LABS 1 drug
UPJOHN 1 drug
By Therapeutic Area
CNS 9 drugs
Drugs by Company PRO
MEDICAP LABS 1 drug
UPJOHN 1 drug
Apotex 1 drug
PF PRISM CV 1 drug
ALEMBIC 1 drug
KAMAT 1 drug
PRINSTON INC 1 drug
By Therapeutic Area
CNS 9 drugs
VENLAFAXINE HYDROCHLORIDE, EFFEXOR XR, PAXIL CR, PRISTIQ +5 more
Indications Treated
Major Depressive DisorderGeneralized Anxiety DisorderSocial Anxiety DisorderPanic DisorderPremenstrual Dysphoric Disorder
All Drugs Targeting SERT
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| VENLAFAXINE HYDROCHLORIDE | MEDICAP LABS | 2006 | 4 | CNS |
| EFFEXOR XR | UPJOHN | 1997 | 4 | CNS |
| PAXIL CR | Apotex | 1999 | 4 | CNS |
| PRISTIQ | PF PRISM CV | 2008 | 1 | CNS |
| VILAZODONE HYDROCHLORIDE | ALEMBIC | 2019 | 1 | CNS |
| FETZIMA | AbbVie | 2013 | 1 | CNS |
| RALDESY | KAMAT | 2024 | 1 | CNS |
| LEVOMILNACIPRAN HYDROCHLORIDE | PRINSTON INC | 2019 | 1 | CNS |
| VIIBRYD | AbbVie | 2011 | 1 | CNS |